Evaluation of Prognostic Factors effect on Survival time in patients with Colorectal Cancer, Based on Weibull Competing-Risks Model
Gastroenterology and Hepatology from Bed to Bench,
Vol. 10 No. 1 (2017),
11 February 2017
Aim: The aim of this study was to assess the association between survival of patients with colorectal cancer and prognostic factors in a competing risks parametric model using Weibull distribution.
Background: The prognosis of colorectal cancer is relatively good in terms of survival time. In many prognostic studies, patients may be exposed to several types of competing events. These different causes of death are called competing risks.
Methods: Data recorded from 372 patients with colorectal cancer who registered in Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences (Tehran, Iran) from 2004 to 2015 in a retrospective study. Analysis was performed using competing risks model and Weibull distribution. Software used for data analysis was R, and significance level was regarded as 0.05.
Results: The result indicated that, at the end of follow-up, 111 (29.8%) death was from colorectal cancer and 14 (3.8%) death was due to other diseases. The average body mass index (BMI) was 24.61(SD 3.98). The mean survival time for a patient in 372 was 62.05(SD 48.78) month with median equals to 48 months. According to competing-risks method, only stageIII ( HR, 1.69; 95% CI, 1.246-2.315 ), stageIV( HR, 4.51; 95% CI,2.91-6.99 ) and BMI( HR, 0.96; 95% CI, 0.96-0.975) have a significant effect on patient’s survival time.
Conclusion: This study indicated pathologic stage(III,IV) and BMI as the prognosis, using Weibull model with competing risks analysis, while other model without the competing events leads to significant predictors which may due to over-estimation.
- Survival analysis - Competing-risks - Colorectal cancer - Weibull model
How to Cite
Dolatkhah R, Somi MH, Bonyadi MJ, Asvadi Kermani I, Farassati F, Dastgiri S. Colorectal cancer in Iran: molecular epidemiology and screening strategies. Journal of cancer epidemiology. 2015;2015.
-Li C, Lu HJ, Na FF, Deng L, Xue JX, Wang JW, et al. Prognostic role of hypoxic inducible factor expression in non-small cell lung cancer: a meta-analysis. Asian Pac J Cancer Prev 2013; 14(6): 3607-3612.
- American Cancer Society (2015) Cancer Facts & Figures 2015. American
Azeem S, Gillani SW, Siddiqui A, Jandrajupalli SB, Poh V, Syed SS. Diet and Colorectal Cancer Risk in Asia--a Systematic Review. Asian Pacific journal of cancer prevention: APJCP. 2015;16(13):5389.
- Alwan A. Global status report on noncommunicable diseases 2010.: World Health Organization; 2011.
Ahmadi A, Mosavi-Jarrahi A, Pourhoseingholi MA. Mortality Determinants in Colorectal Cancer Patients at Different Grades: a Prospective, Cohort Study in Iran. Asian Pac J Cancer Prev. 2015;16(3):1069-72.
Dolatkhah R, Somi MH, Kermani IA, Ghojazadeh M, Jafarabadi MA, Farassati F, et al. Increased colorectal cancer incidence in Iran: a systematic review and meta-analysis. BMC public health. 2015;15(1):1.
-Pourhoseingholi MA, Zali MR. Colorectal cancer screening: Time for action in Iran. World J Gastrointest Oncol. 2012;4(4):82-3.
Baghestani AR, Gohari MR, Orooji A, Pourhoseingholi MA, Zali MR. Evaluation of parametric models by the prediction error in colorectal cancer survival analysis. Gastroenterol Hepatol Bed Bench. 2015 Summer;8(3):183-7.
-Smith EC, Ziogas A, Anton-Culver H. Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity. JAMA Surg 2013;148:516-23.
-van Walraven C, McAlister FA. Competing risk bias was common in Kaplan–Meier risk estimates published in prominent medical journals. Journal of clinical epidemiology. 2016;69:170-3-8
- O’Connell J, Maggard M, Clifford K. Colon cancer survival rates with the new American joint committee on cancer sixth edition staging. J Natl Cancer Inst 2004; 96: 1420–5.
-Kleinbaum DG, Klein M. Survival analysis: Springer; 1996.
-Belot A, Abrahamowicz M, Remontet L, Giorgi R. Flexible modeling of competing risks in survival analysis. Statistics in medicine. 2010;29(23):2453-68.
- Haidinger G, Waldhoer T, Hackl M, Vutuc C. Survival of patients with colorectal cancer in Austria by sex, age, and stage. Wien Med Wochenschr. 2006; 156(19-20): 549-51.
- Kumar S, Burney IA, Zahid KF, Souza PCD, Belushi MA, Meki TDMWA, et al. Colorectal Cancer Patient Characteristics, Treatment and Survival in Oman–a Single Center Study. Asian Pac J Cancer Prev. 2015;16:4853-8.
-O’Connell J, Maggard M, Clifford K. Colon cancer survival rates with the new American joint committee on cancer sixth edition staging. J Natl Cancer Inst 2004; 96: 1420–5.
- Cancer Statistics in Japan: Colon Cancer (1985–1996) National Cancer Center. 1 December 2004, 19 July 2006 [http://www.ncc.go.jp/en/statistics/1999/figures/f10- 2.html].
-Gatta G, Capocaccia R, Sant M, et al (2000). Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut, 47, 533-8.
-Nilsen TL, Vatten LJ (2001). Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis. British J Cancer, 84, 417.
-Morris EJ, Sandin F, Lambert PC, Bray F, Klint A, Linklater K, Robinson D, Pahlman L, Holmberg L, Moller H. A population-based comparison of the survival of patients with colorectal cancer in England, Norway and Sweden between 1996 and 2004. Gut 2011, 60 (8):1087–1093.
-National Cancer Intelligence Network: Cancer Incidence and Survival By Major Ethnic Group, England, 2002–2006. London; 2009.
-Møller H, Sandin F, Robinson D, Bray F, Klint Å, Linklater KM, et al. Colorectal cancer survival in socioeconomic groups in England: variation is mainly in the short term after diagnosis. European Journal of Cancer. 2012;48(1):46-53.
-Li X-P, Xie Z-Y, Fu Y-F, et al (2013). Colorectal cancer concealment predicts a poor survival: a retrospective study. Asian Pacific Journal of Cancer Prevention, 14, 4157-60.
-Brenner H, Hoffmeister M, Arndt V, Haug U (2007) Gender differences in colorectal cancer: implications for age at initiation of screening. Br J Cancer 96: 828–831.
-McArdle CS, McMillan DC, Hole DJ (2003) Male gender adversely affects survival following surgery for colorectal cancer. Br J Surg 90: 711–715.
-Paulson EC, Wirtalla C, Armstrong K, Mahmoud NN (2009) Gender influences treatment and survival in colorectal cancer surgery. Dis Colon Rectum 52: 1982–1991.
-Koo JH, Leong RW (2010) Sex differences in epidemiological, clinical and pathological characteristics of colorectal cancer. J Gastroenterol Hepatol 25: 33–42
- Abstract Viewed: 592 times
- PDF Downloaded: 124 times